Department of Pathology Microbiology and Immunology
-
October 28, 2021
VUMC researchers a step closer to broad ebolavirus protection
-
October 13, 2021
Diagnostic Laboratory Services set for relocation, expansion
Vanderbilt's Diagnostic Laboratory Services are undergoing a major relocation and expansion project. -
October 5, 2021
AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC
Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19. -
September 30, 2021
Molecular imaging of C. diff infection
C. difficile — the leading cause of hospital-associated intestinal infections — induces a rapid influx of bile acids into the gut, which could provide a novel target for blocking infection. -
September 22, 2021
“Ultra-potent” antibody against COVID-19 variants isolated at VUMC
A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. -
September 10, 2021
Caught in a web: study reveals that immune cells cooperate to trap and kill bacteria
Vanderbilt researchers have identified a new antibacterial mechanism that could inspire novel strategies for combating staph and other extracellular bacterial pathogens. -
August 26, 2021
Obese children, young adults at higher risk for thyroid cancer
Children and young adults who are obese are at greater risk for malignant thyroid nodules, according to new study from Monroe Carell Jr. Children’s Hospital at Vanderbilt.